BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10852634)

  • 1. Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum).
    Breidenbach T; Kliem V; Burg M; Radermacher J; Hoffmann MW; Klempnauer J
    Transplantation; 2000 May; 69(10):2229-30. PubMed ID: 10852634
    [No Abstract]   [Full Text] [Related]  

  • 2. [St. John's wort: interaction with cyclosporine increases risk of rejection for the kidney transplant and raises daily cost of medication].
    Beer AM; Ostermann T
    Med Klin (Munich); 2001 Aug; 96(8):480-3. PubMed ID: 11560049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation.
    Moschella C; Jaber BL
    Am J Kidney Dis; 2001 Nov; 38(5):1105-7. PubMed ID: 11684566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interaction of St John's wort with cyclosporin.
    Breidenbach T; Hoffmann MW; Becker T; Schlitt H; Klempnauer J
    Lancet; 2000 May; 355(9218):1912. PubMed ID: 10866469
    [No Abstract]   [Full Text] [Related]  

  • 5. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin.
    Mai I; Krüger H; Budde K; Johne A; Brockmöller J; Neumayer HH; Roots I
    Int J Clin Pharmacol Ther; 2000 Oct; 38(10):500-2. PubMed ID: 11073292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute heart transplant rejection due to Saint John's wort.
    Ruschitzka F; Meier PJ; Turina M; Lüscher TF; Noll G
    Lancet; 2000 Feb; 355(9203):548-9. PubMed ID: 10683008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation.
    Karliova M; Treichel U; Malagò M; Frilling A; Gerken G; Broelsch CE
    J Hepatol; 2000 Nov; 33(5):853-5. PubMed ID: 11097498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St John's Wort supplements endanger the success of organ transplantation.
    Ernst E
    Arch Surg; 2002 Mar; 137(3):316-9. PubMed ID: 11888457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decreased everolimus blood concentration associated with consumption of St. John's wort (Hypericum perforatum) extract sweets].
    Cristóbal Gutiérrez H; Martínez Callejo V; García de la Paz AM; Gómez Gómez D; Ochagavía Sufrategui M; Valero Domínguez M; Colorado Araujo MªLM; Vejo Puente E
    Farm Hosp; 2017 Jul; 41(4):565-566. PubMed ID: 28683711
    [No Abstract]   [Full Text] [Related]  

  • 10. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients.
    Ahmed SM; Banner NR; Dubrey SW
    J Heart Lung Transplant; 2001 Jul; 20(7):795. PubMed ID: 11474706
    [No Abstract]   [Full Text] [Related]  

  • 12. St John's wort: a hidden risk for transplant patients.
    Turton-Weeks SM; Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
    Prog Transplant; 2001 Jun; 11(2):116-20. PubMed ID: 11871046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
    Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction of herbal tea containing St. John's wort with cyclosporine.
    Alscher DM; Klotz U
    Transpl Int; 2003 Jul; 16(7):543-4. PubMed ID: 12677367
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers.
    Burstein AH; Horton RL; Dunn T; Alfaro RM; Piscitelli SC; Theodore W
    Clin Pharmacol Ther; 2000 Dec; 68(6):605-12. PubMed ID: 11180020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of St John's wort (Hypericum perforatum).
    De Smet PA; Touw DJ
    Lancet; 2000 Feb; 355(9203):575-6. PubMed ID: 10683028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug interactions of Hypericum perforatum (St. John's wort) are potentially hazardous].
    Baede-van Dijk PA; van Galen E; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 2000 Apr; 144(17):811-2. PubMed ID: 10800553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction between St. John's wort and cyclosporine.
    Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
    Ann Pharmacother; 2000 Sep; 34(9):1013-6. PubMed ID: 10981246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.